Renal angiomyolipoma
Also known as: Renal AML, Kidney angiomyolipoma, Angiomyolipoma of the kidney
Renal angiomyolipoma (AML) is a predominantly benign mesenchymal neoplasm comprising dysmorphic blood vessels, smooth muscle, and adipose tissue. Clinical management prioritises diagnostic imaging, haemorrhage risk stratification, and longitudinal urological surveillance. Research indicates that while absolute size is not an autonomous threshold for surgical intervention, factors including tuberous sclerosis complex (TSC), lesions ≥4 cm, hypervascularity, and exophytic growth patterns correlate with increased rupture risk. Morphological changes in non-fatty solid components necessitate investigation for concurrent malignancy. Current evidence does not demonstrate that acupuncture or Chinese herbal medicine can induce lesion regression, prevent haemorrhage, or enhance renal outcomes. TCM is restricted to the management of concurrent constitutional symptoms following comprehensive medical evaluation and must not substitute for radiological surveillance, pharmacotherapy, embolisation, or surgical intervention.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Adhere to all scheduled diagnostic imaging and urological consultations; maintain personal records of all radiological reports to facilitate longitudinal comparative analysis.
- •Document instances of flank pain, haematuria, fatigue, or dizziness; seek prompt medical evaluation for any new symptoms rather than awaiting routine follow-up.
- •Consult with a urologist regarding participation in contact sports, the risk of abdominal trauma, and physical activity restrictions based on specific lesion characteristics.
- •Maintain regular nutritional intake, consistent sleep hygiene, and low-impact physical activity; adhere to prescribed fluid intake protocols and avoid the use of unsupervised herbal supplements.
Cautions & Contraindications
- •Defer acupuncture and herbal treatment if haemorrhage is suspected or the patient is clinically unstable; emergency assessment takes priority. This is a precaution based on the reported severity of AML rupture, not an acupuncture trial finding.[]
- •Do not needle deeply over the renal angles, flank mass or affected abdominal region. This anatomical precaution is conservative in a potentially haemorrhagic lesion; the supplied study does not test needling safety.[]
- •Do not use symptom improvement, a TCM pattern label or previous fat-containing imaging to justify delaying investigation of a new solid component or changing lesion. Specialist reassessment remains necessary.[]
When to reassess or seek care again
Review any adjunctive symptom care after 2–4 weeks using a 0–10 symptom score, sleep disruption nights per week, fatigue-related activity limits and adverse effects. Stop or revise care if there is no meaningful benefit. New flank pain, visible haematuria or unexplained worsening fatigue requires medical review rather than waiting for this interval; severe pain or instability requires emergency assessment. Imaging intervals and intervention decisions remain with urology. The supplied evidence consists of one relevant imaging case report and one retrospective rupture-risk study; neither establishes TCM efficacy. Record 2 concerns a different pulmonary diagnosis, and record 4 has no supplied abstract, so neither supports additional treatment claims. Molecular findings do not demonstrate patient benefit.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Journal of clinical ultrasound : JCU · 2026
- BMC pulmonary medicine · 2026
- Open medicine (Warsaw, Poland) · 2026
- Asian journal of surgery · 2024
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
